Corrigendum: ASK1-interacting protein 1 acts as a novel predictor of type 2 diabetes.

Song, Zhigao; Chen, Cong; He, Jipei; Liu, Bixia; Ji, Weidong; Wu, Liangping; He, Li

Song, Zhigao; Chen, Cong; He, Jipei; Liu, Bixia; Ji, Weidong; Wu, Liangping; He, Li.

Afiliación

Song Z; Center for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Chen C; Department of Cardiovascular Surgery, Zhujiang Hospital of Southern Medical University, Guangzhou, China.
He J; Center for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Liu B; Department of Metabolic Surgery, Your Doctor Medical Group, Guangzhou, China.
Ji W; Center for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Wu L; Center for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
He L; Department of Metabolic Surgery, Your Doctor Medical Group, Guangzhou, China.

Front Endocrinol (Lausanne) ; 13: 981231, 2022.

Article en En | MEDLINE | ID: mdl-36051384

Palabras clave

AIP1; adipose inflammation; insulin resistance; type 2 diabetes; visceral adipose

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google